Study reports new compound that halts replication of COVID by targeting ‘Mac-1’ protein in cell models

Research appearing in the Journal of Medicinal Chemistry shows for the first time SARS-CoV-2, the virus responsible for COVID-19, can be inhibited from replicating in living cell cultures using a compound that targets “Mac-1,” a protein key to defending SARS-CoV-2 against the human immune response.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup